MedPath

Siravyadha(blood letting)in vata raktha (gout)

Phase 4
Conditions
Health Condition 1: M100- Idiopathic gout
Registration Number
CTRI/2024/01/062060
Lead Sponsor
Dr Sambu Surendran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a.Subject with hyperuricemia and presenting with lakshanas of Vatarakta.

b.Chronicity less than 5 years,

c.Not associated with complete joint destruction.

d.Uric acid above 7 mg/dl

Exclusion Criteria

a.Subject with major illness like hepatitis, AIDS, malignancy and RA factor positive.

b.Subject with uncontrolled diabetes mellitus and hypertension, Koch’s arthritis, Septic arthritis, Chronic renal failure, Severe Systemic multi organ syndromes and uric acid cristal stones.

c.Subjects on opioids, anticoagulant drugs.

d.Classical contraindications for siravyadha procedure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath